Press
-
A statement from SRI Education
As an organization and as individuals, we must listen, speak, and act to combat racial injustice. SRI Education commits to take 4 steps towards this goal.
-
75 Years of Innovation: Ultrasound
Ultrasound is used across a wide variety of medical imaging needs.
-
Black Lives Matter – A letter from our CEO
The time has come for all Americans to band together and commit to ending the cycle of violence and unjust treatment the Black community experiences every day.
-
75 Years of Innovation: Virtual Advertising Insertion (Augmented Reality)
Setting the standards for augmented reality for broadcasting.
-
Featured innovator: Nathan Collins
Nathan Collins, former CSO of SRI Biosciences discusses current and future plans for leveraging AI to help advance modern chemistry and SRI’s related work in the biosciences industry
-
75 Years of Innovation: FOX Three Molecular Guidance System
How the FOX Three Molecular Guidance System helps large drugs cross barriers
-
Developing the next generation of PCR diagnostics for point-of-contact screening
SRI International investigator awarded National Science Foundation grant for development of a revolutionary point of contact diagnostic for infectious diseases The current world-wide COVID-19 pandemic underscores the need for rapid and widespread screening for emerging infectious agents. As emerging infectious diseases can spread rapidly, government agencies have made developing detection technologies a priority. To explore…
-
Hope for struggling readers — early evidence from the use of augmented reality
Research from a team of SRI education researchers explored how augmented reality (AR) and virtual reality (VR) have the potential to complement what special education educators do for students with dyslexia
-
Nathan Collins talks about how the SynFini automated chemistry platform is accelerating drug development and discovery.
Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
-
Nathan Collins talks about the SynFini™ automated chemistry platform (Part 1)
Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: https://www.sri.com/case-studies/synfini. Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part one of this episode of The Dish TV they discuss the processes and problems of new drug discovery…
-
Nathan Collins talks about integrating AI with the SynFini™ Platform (Part 2)
Nathan Collins discusses how integrating AI with the SynFini automated chemistry platform is poised to shape the future of drug discovery and development. Learn more about SynFini at: https://www.sri.com/case-studies/synfini Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part two of this episode of The Dish TV they discuss…
-
75 Years of Innovation: Centibots
The hive mind of robots